Effects of post-renal anemia treatment with the HIF-PHD inhibitor molidustat on adenine-induced renal anemia and kidney disease in mice

• 主要な著者: Lei Li (著者), Daisuke Nakano (著者), Anqi Zhang (著者), Wararat Kittikulsuth (著者), Norihiko Morisawa (著者), Hiroyuki Ohsaki (著者), Norio Suzuki (著者), Masayuki Yamamoto (著者), Akira Nishiyama (著者)
• フォーマット: 図書
• 出版事項: Elsevier, 2020-12-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

The kidneys are the major organs for erythropoietin (EPO) production in adults, and thus, kidney damage results in reduced EPO levels and anemia. Inhibitors of Hypoxia-inducible factor-prolyl hydroxylase domain-containing protein (HIF-PHD) are awaited as new therapeutic options for renal anemia. It...